COVID meds like Paxlovid will soon have big price tags
Americans have been getting COVID treatments such as Paxlovid for free, but that's about to end.
Oct 30, 2023
0
8
Americans have been getting COVID treatments such as Paxlovid for free, but that's about to end.
Oct 30, 2023
0
8
U.S. health officials warned parents on Thursday not to use three popular powdered infant formulas manufactured at an Abbott plant in Michigan that investigators recently linked to bacterial contamination.
Feb 18, 2022
0
4
In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how health care providers—and the public—view weight loss.
Jun 1, 2023
0
24
For those fearing their memories are fading, the ads provide hope.
Jul 13, 2023
0
0
(HealthDay)—The American Medical Association (AMA) is calling for a ban on all e-cigarettes and vaping products not approved by the U.S. Food and Drug Administration to help people quit smoking tobacco cigarettes.
Nov 20, 2019
0
1
An experimental treatment for Alzheimer's failed again in a widely anticipated study, disappointing many who had hoped drugmaker Eli Lilly had finally found a way to slow the progression of the mind-robbing disease.
Nov 23, 2016
0
30
US doctors who receive direct payments from opioid manufacturers tend to prescribe more opioids than doctors who receive no such payments, according to new research published by Addiction. The report found that the association ...
Jan 22, 2019
0
3
A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma ...
Nov 22, 2022
0
26
In 2016, recognizing that lack of research in female animals was hampering the success of treatments for mood disorders, the National Institutes of Health (NIH) changed its policy for basic research to include sex as a biological ...
Aug 1, 2023
0
23
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research.
Feb 4, 2019
0
15